Imaging Endpoints Appoints Jatinder Kaur as Chief Operating Officer
Global Growth to Connect Imaging to the Cure Driving Impactful Regulatory Approvals and Expansion
Imaging Endpoints (IE), based in Scottsdale Arizona with eight offices in six countries, announced today the promotion of Jatinder Kaur to Chief Operating Officer (COO). Jatinder has most recently served as Executive Vice President of Operations at Imaging Endpoints, has been with the Company for over eight years, has led the Company’s global expansion, and has helped build IE into one of the largest imaging CROs (iCROs) globally and the largest oncology-focused iCRO.
Under the leadership and direction of Jatinder Kaur, Imaging Endpoints is realizing its vision to Connect Imaging to the Cure(TM) by customizing the imaging for each clinical trial to optimize the opportunity to demonstrate efficacy. Jatinder leverages her over 20 years of imaging CRO experience to oversee the operating departments that design and execute the most customized imaging in the industry while integrating with IE’s world-renown Compliance and Regulatory Affairs (CRA) department to help facilitate many of the most impactful new drug approvals in oncology across the globe.
In her new and expanded role Jatinder will lead Operations to ensure Imaging Endpoints remains the global industry leader in oncology by continuing to go further than any iCRO to optimize the opportunity to demonstrate efficacy. IE achieves this by customizing the imaging plan to each unique experimental agent and the specific disease-type the study targets, often by including critical clarifications and/or modifications to standard imaging criterion such as RECIST1.1/iRECIST. IE also improves the opportunity to demonstrate efficacy through advanced imaging where IE is the industry leader (with over fifty publications in peer-reviewed publications) in providing supportive data for development programs and regulatory submissions.
Imaging Endpoints’ strong growth and success in new drug approvals has accelerated this year, enabling the Company to recognize, promote, reward, and facilitate further growth of the team members that have helped IE achieve its status as the preeminent iCRO in oncology. Imaging Endpoints continues to add new staff across the globe within Imaging Operations, Medical and Scientific Affairs, Data Management, Compliance and Regulatory Affairs, Innovation and Information Technology, and within the Company’s Research Endpoints and Clinical Endpoints subsidiaries. See www.imagingendpoints.com for a list of openings with opportunity for dynamic growth and contribution toward Connecting Imaging to the Cure.
About Imaging Endpoints:
Imaging Endpoints (IE) is an imaging CRO that is passionately focused on it’s vision to Connect Imaging to the Cure. Everything IE does is aligned with this singular purpose. IE teams work every day excited to advance imaging science, technology, and services to bring curative technologies to humankind. IE has supported many of the most impactful new drug approvals in oncology over the past few years and strives to help each sponsor in this same manner. The IE team works relentlessly to customize the imaging plan and execute with excellence to optimize the opportunity to demonstrate efficacy.
IE is one of the largest iCROs globally, the largest focused in oncology, and it’s experience spans the customization of imaging to facilitate regulatory approval in hundreds of trials across all phases of development, including many of the most impactful approvals in the industry. IE also provides additional data to support efficacy by integrating advanced imaging technologies into clinical trials such as CD8 imaging, tumor growth kinetics, radiomics and artificial intelligence where over fifty peer-reviewed publications have established the company as the industry leader.
Imaging Endpoints is headquartered in Scottsdale, AZ, with offices in Cambridge, MA; London, UK; Leiden, Netherlands; Basel, Switzerland; Hyderabad, India and Shanghai, China. IE is an affiliate of HonorHealth, one of the largest healthcare systems nationally, and an affiliate of Southwest Medical Imaging, Ltd. (SMIL/RadPartners), part of the largest private radiology group in the U.S.
